| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90961 |
|
20,406 |
17,900 |
$1.77M |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
9,415 |
8,184 |
$888K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,859 |
5,250 |
$304K |
| 90962 |
|
4,775 |
4,288 |
$274K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,505 |
674 |
$66K |
| 90966 |
|
148 |
146 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
144 |
141 |
$13K |
| 99222 |
Initial hospital care, per day, moderate complexity |
161 |
146 |
$9K |
| 99443 |
|
188 |
138 |
$9K |
| 99496 |
|
57 |
54 |
$6K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
505 |
476 |
$2K |
| 99442 |
|
14 |
12 |
$698.52 |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
16 |
12 |
$0.00 |
| 99223 |
Prolong inpt eval add15 m |
27 |
26 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
12 |
$0.00 |